This vulnerability is further exacerbated by mutations in the PD-L1 gene and alterations in chromosome 9p24.1, leading to increased PD-L1 and PD-1 in the tumor microenvironment (TME) via JAK-STAT signaling [165]. The gene discussed is CD274; the disease is neoplasm.